Roche reviews

The company has always been far too internally focused. It is a deep seated element of the Roche culture that has not been effectively countered and so now it is just being ignored, and consequences are coming to the surface. Long term internal focus is costly in the long term. The company has changed over recent years as margins have dwindled and the diagnostics branch prepares to greet commoditisation of its once dominant product offering. Experience as a quality is stepping aside for generic thinking and business-by-textbook. The Dx branch did not take enough of advantage of its leading position while its competitors suffered major setbacks. Now the competition has caught up, it is becoming difficult to differentiate, meaning an increasing reliance on customer loyalty, which benefits from long term relationships with trusted company specialists, whose experience is now undervalued. Available resources are reallocated to patch ailing hardware that should have been obsolesced many years ago. Take your experience somewhere where they know it is valuable and and never let them tell you that you can't do what you believe.

Very poor management. There are leadership values that look great but mean nothing. HR are very weak and any sign of dissent is strongly discouraged.